Acacia Pharma Overview
- Year Founded
-
2007
- Status
-
Acquired/Merged
- Employees
-
72
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$104M
Acacia Pharma General Information
Description
Developer of pharmaceutical products designed to offer specialized medicinal products to improve the care of patients undergoing serious medical treatments such as surgery, invasive procedures, or chemotherapy. The company focuses on developing and commercializing novel products to improve the care of patients undergoing medical treatments such as surgery, invasive procedures and chemotherapy.
Contact Information
Website
www.acaciapharma.com(Operating Subsidiary)
Corporate Office
- The Officers' Mess
- Royston Road
- Cambridge CB22 4QH
- England, United Kingdom
Corporate Office
- The Officers' Mess
- Royston Road
- Cambridge CB22 4QH
- England, United Kingdom
Acacia Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 09-Jun-2022 | $104M | Completed | Generating Revenue | ||
| 11. PIPE | 19-Feb-2021 | Completed | Generating Revenue | |||
| 10. PIPE | 14-Aug-2020 | Completed | Generating Revenue | |||
| 9. PIPE | 02-Jan-2020 | Completed | Generating Revenue | |||
| 8. IPO | 05-Mar-2018 | Completed | Generating Revenue | |||
| 7. Later Stage VC | 21-Nov-2017 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 25-Aug-2015 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B) | 06-Jun-2014 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series B) | 03-Sep-2013 | $23.5M | $34.6M | Completed | Generating Revenue | |
| 3. Early Stage VC | 01-Feb-2012 | $1.11M | $11.1M | Completed | Generating Revenue |
Acacia Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C Preferred | ||||||||
| B Preferred | ||||||||
| Series A | 9,692,856 | $0.000156 | $1.2 | $1.2 | 4x | $1.2 | 22.82% | |
| Series S | 3,910,732 | $0.000156 | $1.2 | $1.2 | 5x | $1.2 | 9.21% |
Acacia Pharma Comparisons
Industry
Financing
Details
Acacia Pharma Competitors (35)
One of Acacia Pharma’s 35 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pfizer (Vienna) | Corporation | Vienna, Austria | ||||
| Pfizer Pakistan | Corporation | Karachi, Pakistan | ||||
| Helsinn Healthcare | Corporation | Lugano, Switzerland | ||||
| Ardelyx | Formerly VC-backed | Waltham, MA | ||||
| Indivior | Corporate Backed or Acquired | North Chesterfield, VA |
Acacia Pharma Patents
Acacia Pharma Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202108238-D0 | Thearpy of post-operative nausea and vomiting | Inactive | 09-Jun-2021 | ||
| AU-2021305446-A1 | Therapy of post-operative nausea and vomiting | Active | 06-Jul-2020 | ||
| AU-2021305446-B2 | Therapy of post-operative nausea and vomiting | Active | 06-Jul-2020 | ||
| CA-3187665-A1 | Therapy of post-operative nausea and vomiting | Pending | 06-Jul-2020 | ||
| EP-4175631-A1 | Therapy of post-operative nausea and vomiting | Pending | 06-Jul-2020 | A61K31/40 |
Acacia Pharma Signals
Acacia Pharma Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Cosmo Pharmaceuticals | Corporation | Minority | ||
| Eight Roads | Corporate Venture Capital | Minority | ||
| F-Prime | Venture Capital | Minority | ||
| Gilde Healthcare | PE/Buyout | Minority | ||
| Lundbeckfonden BioCapital | Venture Capital | Minority |
Acacia Pharma ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
Acacia Pharma FAQs
-
When was Acacia Pharma founded?
Acacia Pharma was founded in 2007.
-
Where is Acacia Pharma headquartered?
Acacia Pharma is headquartered in Cambridge, United Kingdom.
-
What is the size of Acacia Pharma?
Acacia Pharma has 72 total employees.
-
What industry is Acacia Pharma in?
Acacia Pharma’s primary industry is Pharmaceuticals.
-
Is Acacia Pharma a private or public company?
Acacia Pharma is a Private company.
-
What is the current valuation of Acacia Pharma?
The current valuation of Acacia Pharma is .
-
What is Acacia Pharma’s current revenue?
The current revenue for Acacia Pharma is .
-
How much funding has Acacia Pharma raised over time?
Acacia Pharma has raised $190M.
-
Who are Acacia Pharma’s investors?
Cosmo Pharmaceuticals, Eight Roads, F-Prime, Gilde Healthcare, and Lundbeckfonden BioCapital are 5 of 7 investors who have invested in Acacia Pharma.
-
Who are Acacia Pharma’s competitors?
Pfizer (Vienna), Pfizer Pakistan, Helsinn Healthcare, Ardelyx, and Indivior are some of the 35 competitors of Acacia Pharma.
-
When was Acacia Pharma acquired?
Acacia Pharma was acquired on 09-Jun-2022.
-
Who acquired Acacia Pharma?
Acacia Pharma was acquired by Eagle Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process